Cargando…
Discriminant analysis of intermediate brain atrophy rates in longitudinal diagnosis of alzheimer's disease
Diagnosing Alzheimer's disease through MRI neuroimaging biomarkers has been used as a complementary marker for traditional clinical markers to improve diagnostic accuracy and also help in developing new pharmacotherapeutic trials. It has been revealed that longitudinal analysis of the whole bra...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305898/ https://www.ncbi.nlm.nih.gov/pubmed/22035255 http://dx.doi.org/10.1186/1746-1596-6-105 |